Intrinsic Value of S&P & Nasdaq Contact Us

Abivax S.A. ABVX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • FR • USD

SharesGrow Score
59/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$145.67
+15.8%

Stock Statistics — ABVX

Abivax S.A. (ABVX) has a market capitalization of $8.25B and trades at $125.80. The 52-week range is 4.77-148.83.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -27.1, Earnings Per Share (EPS) of $-4.65.

The stock has a beta of -0.10, operates in the Healthcare sector.

Trading Data
Current Price$125.80
52-Week Range4.77-148.83
Volume934.17K
Avg Volume (30D)989.46K
Market Cap$8.25B
Beta (1Y)-0.10
Company
IPO Date2023-10-20
Employees69
CEODidier Blondel
CountryFR
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS00370M1036
CUSIP00370M103
Income (Latest Year)
Gross Profit$-1.03M
EBITDA$-239.7M
Operating Income$-240.73M
Net Income$-322.84M
EPS$-4.65
EPS Diluted$-4.65
Shares Outstanding$69.53M
Balance Sheet (Latest Year)
Total Assets$584.09M
Current Assets$551.01M
Cash & ST Investments$530.16M
Total Liabilities$129.08M
Total Debt$32.08M
Net Debt$-484.39M
Total Equity$455.01M
Debt / Equity0.07
Valuation Ratios
P/E Ratio-27.1
P/B Ratio18.13
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message